Literature DB >> 11386490

Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug-abusing humans.

C R Rush1, W D Essman, C A Simpson, R W Baker.   

Abstract

The reinforcing effects of methylphenidate (20-40 mg), d-amphetamine (10-20 mg), and placebo were assessed in eight healthy, non-sleep-deprived, non-drug-abusing outpatient volunteers. A modified progressive-ratio schedule was used to assess drug reinforcement in which a sampling session always preceded a self-administration session. During sampling sessions, volunteers received a drug dose to acquaint them with the drug effects. Drug doses were administered in eight identical capsules (i.e., each capsule contained 12.5% of the total dose). During self-administration sessions, which generally were conducted the next day, volunteers were given eight opportunities to work on a computer and could earn all, or some, of the capsules that were administered the previous day. To earn the first capsule, volunteers had to click a computer mouse 50 times. The number of clicks required to earn each additional capsule doubled (i.e., 100, 200, 400, 800, 1,600, 3,200, and 6,400 clicks). The dependent measure on this task was the break point (i.e., the last ratio completed). To characterize more fully the behavioral effects of methylphenidate and d-amphetamine, a battery of subject-rated drug-effect questionnaires, performance tasks, and physiologic measures was also used. Both doses of d-amphetamine increased the break point significantly above placebo levels, whereas only the high dose of methylphenidate did so. Break-point values for the doses of methylphenidate and d-amphetamine that maintained the greatest responding did not differ significantly. Methylphenidate and d-amphetamine produced some stimulantlike subject-rated drug effects (e.g., increased ratings of "drug liking"). These data suggest that methylphenidate, like d-amphetamine, can function as a reinforcer under a modified progressive-ratio schedule and, by inference, has at least some abuse potential in healthy, non-sleep-deprived, non-drug-abusing volunteers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11386490     DOI: 10.1097/00004714-200106000-00005

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  45 in total

Review 1.  Psychostimulant treatment of cocaine dependence.

Authors:  John J Mariani; Frances R Levin
Journal:  Psychiatr Clin North Am       Date:  2012-04-26

2.  Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance.

Authors:  Craig R Rush; William W Stoops; Joshua A Lile; Paul E A Glaser; Lon R Hays
Journal:  Psychopharmacology (Berl)       Date:  2010-11-12       Impact factor: 4.530

3.  Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans.

Authors:  William W Stoops; J Adam Bennett; Joshua A Lile; Rajkumar J Sevak; Craig R Rush
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-08-28       Impact factor: 5.067

Review 4.  Food reinforcement and eating: a multilevel analysis.

Authors:  Leonard H Epstein; John J Leddy; Jennifer L Temple; Myles S Faith
Journal:  Psychol Bull       Date:  2007-09       Impact factor: 17.737

5.  Caffeine choice prospectively predicts positive subjective effects of caffeine and d-amphetamine.

Authors:  Stacey C Sigmon; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2011-05-19       Impact factor: 4.492

6.  The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: influence of sensation-seeking status.

Authors:  William W Stoops; Joshua A Lile; C Glenn Robbins; Catherine A Martin; Craig R Rush; Thomas H Kelly
Journal:  Addict Behav       Date:  2006-10-02       Impact factor: 3.913

7.  Assessing methylphenidate preference in ADHD patients using a choice procedure.

Authors:  Emily MacDonald Fredericks; Scott H Kollins
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

8.  Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors.

Authors:  P K Thanos; C Bermeo; M Rubinstein; K L Suchland; G J Wang; D K Grandy; N D Volkow
Journal:  J Psychopharmacol       Date:  2009-03-12       Impact factor: 4.153

9.  Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans.

Authors:  William W Stoops; Andrea R Vansickel; Joshua A Lile; Craig R Rush
Journal:  Pharmacol Biochem Behav       Date:  2007-04-05       Impact factor: 3.533

Review 10.  Treatment strategies for co-occurring ADHD and substance use disorders.

Authors:  John J Mariani; Frances R Levin
Journal:  Am J Addict       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.